{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:50:46Z","timestamp":1760298646399},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.clinthera.2012.11.009","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T06:46:22Z","timestamp":1356677182000},"page":"77-86","source":"Crossref","is-referenced-by-count":17,"title":["Assessment of the Efficacy and Tolerability of 2 Formulations of Atorvastatin in Korean Adults With Hypercholesterolemia: A Multicenter, Prospective, Open-Label, Randomized Trial"],"prefix":"10.1016","volume":"35","clinical-trial-number":[{"clinical-trial-number":"nct01285544","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sang-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Ki","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taek-Jong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.11.009_bib1","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.clinthera.2007.11.002","article-title":"Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia","volume":"29","author":"Lee","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2012.11.009_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2012.11.009_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9149(03)00004-3","article-title":"Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals","volume":"91","author":"Shepherd","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2012.11.009_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1536\/jhj.42.725","article-title":"A randomized, double-blind, placebo-controlled, 8-week study to evaluate the efficacy and safety of once daily atorvastatin (10 mg) in patients with elevated LDL-cholesterol","volume":"42","author":"Wang","year":"2001","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.clinthera.2012.11.009_bib5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1067\/mhj.2002.128049","article-title":"Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia","volume":"144","author":"Olsson","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2012.11.009_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0021-9150(97)06066-8","article-title":"A brief review paper of the efficacy and safety of atorvastatin in early clinical trials","volume":"131","author":"Bakker-Arkema","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2012.11.009_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2012.11.009_bib8","doi-asserted-by":"crossref","first-page":"122A","DOI":"10.1016\/S0002-9149(05)80033-5","article-title":"Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease","volume":"76","author":"Eichstadt","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2012.11.009_bib9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.clinthera.2005.07.007","article-title":"A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia","volume":"27","author":"Park","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2012.11.009_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(96)05190-2","article-title":"Statins do more than just lower cholesterol","volume":"348","author":"Vaughan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2012.11.009_bib11","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.amjcard.2008.07.023","article-title":"Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)","volume":"102","author":"Johnson","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2012.11.009_bib12","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2006.03.034","article-title":"Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study","volume":"47","author":"Scirica","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2012.11.009_bib14","series-title":"Guideline for Good Clinical Practice","year":"2002"},{"key":"10.1016\/j.clinthera.2012.11.009_bib16","series-title":"International Monitoring of Adverse Reactions to Drugs: Adverse Reaction Terminology","year":"1992"},{"key":"10.1016\/j.clinthera.2012.11.009_bib17","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2012.11.009_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2012.11.009_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2012.11.009_bib20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812006571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812006571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T20:59:42Z","timestamp":1539982782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812006571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0149291812006571"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.11.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}